This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Novo Nordisk is licensing rights to a United Biotechnology drug that sparks metabolic effects by binding to and activating receptors for GLP-1, GIP, and glucagon. Separately, the pharma giant said its recently announced discounted price for obesity medication Wegovy is now expanding to traditional pharmacies. The post Novo Nordisk Bets $200M on Triple-Targeting Drug for Obesity and Other Metabolic Diseases appeared first on MedCity News.
Want to thrive in medical sales? In this episode, TJ, a regional business director specializing in cardiology, shares insider strategies for successfrom fostering a growth mindset to mastering self-leadership. Learn how top performers refine their processes, understand their motivations, and leverage innovation to drive sales in coronary artery disease and structural heart technologies.
Considering the lack of high quality data, companies that excel in compiling and managing data effectively are attracting interest from industry partners and distinguishing themselves from their rivals. Here are some of the ways emerging AI applications are fueling and redefining the need for RWD across HCLS. The post How AI is Accelerating the Need for Real World Data in Healthcare and Life Sciences appeared first on MedCity News.
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
Forward by Stewart Gandolf, Chief Executive Officer At Healthcare Success, we understand that a patients journey often beings with a search query. In this blog, our Technical Program Manager, Victoria Shepherd, explores the critical role of symptom search optimization. She shares how organizations can leverage this healthcare marketing trend to engage potential patients early and offers key strategies for optimizing symptom-based searches to drive patient conversions.
Introduction The healthcare industry is undergoing a significant transformation, and ad budgeting is at the center of this shift. With the rapid expansion of digital platforms, evolving patient expectations, and the increasing role of AI-driven marketing, pharmaceutical companies and healthcare brands are allocating more resources to advertising in 2025.
Introduction The healthcare industry is undergoing a significant transformation, and ad budgeting is at the center of this shift. With the rapid expansion of digital platforms, evolving patient expectations, and the increasing role of AI-driven marketing, pharmaceutical companies and healthcare brands are allocating more resources to advertising in 2025.
Novartiss Fabhalta is the first FDA-approved therapy for C3 glomerulopathy. But Apellis Pharmaceuticals Empaveli has superior clinical data, and that drug has been submitted for FDA review in the same rare kidney disease as well as another one that does not yet have an approved therapy. The post Novartis Nabs First FDA Nod in Rare Kidney Disease, But Apellis Pharma Is on Its Heels appeared first on MedCity News.
Innovative research suggests that a combination cleaning approach can reliably eliminate mycoplasma, viruses, and endotoxin contaminants in biosafety cabinets. The study proposed that wiping with various disinfectants (distilled water, ethanol, and benzalkonium chloride (BKC)), together with UV irradiation was optimal for changeover cleaning. Optimising contaminant removal in biosafety cabinets Mizuno et al. stated that their study is the first to provide reference data of different cleaning met
Corporate incentive trips are about more than just rewarding employees for their hard worktheyre about creating a transformative experience that motivates, inspires, and propels the team toward greater success. Whether its a tropical getaway, a luxury retreat, or an unforgettable adventure, the goal is to recharge your teams spirit, reinforce your companys values, and encourage them to continue striving for excellence.
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
Automation, AI, budget cuts, and evolving digital strategies have prompted a growing question among pharmaceutical marketing teams: Is my pharma marketing job at risk? As companies adapt to more agile workflows and redefine what modern commercialization looks like, the roles of marketing professionals are being evaluated more critically than ever before.
New York Joins Growing Wave of State Health Privacy Laws If you think that patient health data is exclusively regulated by the Health Insurance Portability and Accountability Act (HIPAA) think again. In addition to comprehensive consumer privacy laws (e.g., CCPA), states like Washington, through its My Health My Data Act (MHMDA), are diving headfirst into their own regulations around health information privacy.
MSD (Merck) has gained global rights to develop, manufacture and commercialise an oral small molecule Lipoprotein(a) inhibitor, currently being investigated in a Phase II clinical trial for atherosclerosis.Jiangsu Hengrui Pharmaceuticals Co., Ltd (Hengrui Pharma) has agreed to license its drug candidate HRS-5346 worldwide, excluding the Greater China region.As part of the agreement, MSD will give Hengrui Pharma an initial sum of $200 million in exchange for rights to its Lp(a) inhibitor.
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
The pace of change in healthcare marketing has reached an all-time high. With new platforms, tools, privacy regulations, and patient behaviors evolving every week, teams that fail to adapt risk falling behind. This is especially true when it comes to developing modern pharma marketing strategies. In an industry where precision, compliance, and engagement are critical, staying agile and prepared is more important than ever.
Apellis Pharmaceuticals and Astellas Pharma have the first two FDA-approved therapies for geographic atrophy, but Character Biosciences claims its approach could be best in class for treating this advanced form of dry age-related macular degeneration. The biotech’s Series B round will finance clinical tests of two programs, each addressing a different stage of the disease.
CRMs are meant to help companies make better decisions. That said, too many of us end up drowning in dashboards that provide little value (if theyre looked at all). Reports pile up over time, often built in response to ad-hoc requests or leadership demands for more visibility. The result is what we call dashboard explosion, or in other words, a mess of half-built, rarely used, and redundant reports.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
The US Food and Drug Administration (FDA) has approved Blujepa ( gepotidacin ) antibiotic for uncomplicated urinary tract infections (uUTIs) in female adults and paediatric patients aged 12 years old and over. The first-in-class bactericidal drug is indicated for such infections caused by E scherichia coli, Klebsiella pneumoniae, Citrobacter freundii complex, Staphylococcus saprophyticus and Enterococcus faecalis.
Introduction The pharmaceutical industry faces unique challenges in digital marketing, especially when it comes to reaching healthcare professionals (HCPs) and patients effectively. Ad retargeting has become a powerful tool for pharma marketers, enabling brands to re-engage potential customers who have shown interest but have not yet converted. But how does ad retargeting work in pharma marketing, and what strategies yield the best results?
Navina closed a $55 million Series C funding round led by Goldman Sachs. The company, based in Israel and New York, uses AI to help primary care physicians thrive in value-based care models. The post Navina Snags $55M for Its Value-Based Care AI Copilot appeared first on MedCity News.
How do you build solid analytics learning culture at Fortune 100 companies? Xingchu : Analytics learning culture starts with analytics, and building a data analytics-first culture is critical. This approach means that for every business decision, we start from data and insights, which enables a fact-based conversation. This mindset goes from daily work with each team member to senior business executives.
Peter Wells, CEO of TemperPack, discusses the life sciences industry's shift toward sustainable packaging, particularly in cold chain logistics, to replace outdated petroleum-based materials like expanded polystyrene (EPS). His insights cover the growing importance of sustainability as a business driver, emphasizing efficiency, waste reduction, regulatory pressures, and emerging innovations in biodegradable and recyclable packaging solutions.
Artificial intelligence (AI) is no longer a futuristic concept in healthcareits here, embedded in nearly every touchpoint of modern pharma marketing. From generative AI tools that draft emails to predictive algorithms that segment target audiences, the speed and scale of innovation are staggering. But as pharma marketers race to adopt these tools, a central question looms: Is AI fueling smarter engagement, or setting the stage for a compliance disaster?
While high-acuity options must remain for those that need stronger interventions, millions more could be benefiting from access to low-acuity or minimal interventions. The post The Workforce is Suffering from Chronic Back Pain Its Time for a New Approach appeared first on MedCity News.
ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!
LONDON, 25 March 2025 – The Creative Floor Healthcare Awards have awarded this years Talent & Diversity to four charities – Key4Life, The Ideas Foundation, School of Communication of Arts and Brixton Finishing School. The awards continue to be the only health and wellness award show in the world to donate a percentage of profits towards a Talent & Diversity Fund, that helps people from under-represented communities into health and wellness communication agencies.
Advances in the life sciences are driving a significant increase in the number of temperature-sensitive pharmaceuticals. The packaging industry is meeting the moment with advances of its own, including high-performance, environmentally-friendly materials that allow life science companies meet stringent thermal requirements and ambitious CO2e reduction goals.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
231 
Let's personalize your content